Superbug Resistance Causes 35,000 Deaths Annually in Europe as Experts Urge Action

Bacterial resistance to standard drug treatments causes an estimated 35,000 deaths each year within the European Union, according to recent public health data. The combined mortality and health burden of antimicrobial resistance in the bloc has reached levels comparable to influenza, tuberculosis, and HIV/AIDS combined. A study published in the medical journal The Lancet projects that bacterial resistance could directly cause 39 million deaths globally between 2025 and 2050.

The spread of multidrug-resistant bacteria occurs through interactions between human populations, livestock, and the surrounding environment. According to Fiona Walsh, a professor at Maynooth University in Ireland who researches resistance across human, animal, and environmental health, overusing antibiotics in medicine and agriculture accelerates the proliferation of resistant strains. When standard drug combinations fail to clear infections in patients, effective therapeutic options become severely limited.

Researchers and international health organizations are advocating for a strategy known as the One Health approach, which links human medical care with veterinary practices and environmental management. According to estimates by the World Health Organization, expanded use of existing vaccines could reduce global antibiotic consumption by 2.5 billion doses per year by preventing primary infections before they occur. Improved wastewater treatment facilities and enhanced hygiene standards in agricultural food chains are also cited as necessary containment measures.

Excessive application of antibiotics and chemical disinfectants can also compromise the body's natural microflora located on the skin, in the mouth, and within the digestive tract. Walsh noted that maintaining healthy internal bacterial systems provides protection against pathogenic infections, warning that unnecessary drug use risks damaging these natural defences. Future mitigation efforts focus on expanding vaccine coverage, upgrading sanitation infrastructure, and improving livestock health alongside the targeted development of new antimicrobial therapies.

Written by Thomas Nussbaumer thomas.nussbaumer@alpineweekly.com